1

Biogen discontinues experimental arthritis drug (Reuters)

Reuters - Biogen Idec Inc said on Thursday it will discontinue development of baminercept as a treatment for rheumatoid arthritis after the experimental drug failed to prove effective in a mid-stage trial. Read »
Created by deep Created 7 weeks 4 days ago – Made popular 7 weeks 4 days ago
Category: Science
  • Login to post comments
  • 1

Similar stories

Dying Lawyer's Son, Clintons Beg Biogen to Use Drug (Bloomberg) Created 6 weeks 5 days ago
FDA wants Biogen, Elan drug warning revised (Reuters) Created 14 weeks 8 hours ago
Arthritis drug restores speech in Alzheimer's Created 18 weeks 6 days ago
Cell Therapeutics to buy cancer drug (AP) Created 1 year 15 weeks ago
Investors await bone drug data from Amgen (Reuters) Created 11 weeks 3 days ago
FDA lists drugs under safety probes (Reuters) Created 12 weeks 3 days ago
RocketBoom Founder Fighting For Father’s Life; Meanwhile, Drug Company Is Committing PR Suicide Created 6 weeks 6 days ago

User login

Syndicate

Syndicate content